We provided the evidence that in PDA primary tumors FOXM1 can be co-amplified with genes coding for critical glycolytic enzymes adding further insights on the role of this TF in the regulation of the PDA metabolism. The gene discussed is FOXM1; the disease is Patent ductus arteriosus.